DRTSW

DRTSW

Alpha Tau Medical Ltd. Warrant

$0.245+0.000 (0.000%)

Preço em tempo real

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$0.000

Máximo

$0.000

Mínimo

$0.000

Volume

0.00M

Fundamentos da empresa

Estatísticas de negociação

Notícias relacionadas

GlobeNewswire

Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update

- Interim Jan-2025 results from three trials of Alpha DaRT® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R&D Update Day, showing >90% disease control rate, impressive overall

Ver mais
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire

Alpha Tau to Participate in May Investor Conferences

JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today

Ver mais
Alpha Tau to Participate in May Investor Conferences